AbstractInvasive fungal disease (IFD) is a major cause of morbidity and mortality after hematopoietic stem cell transplantation (HCT). We performed a retrospective review of 271 adults with a hematologic malignancy undergoing allogeneic HCT to determine the incidence of and risk factors for IFD and to examine the impact of IFD on nonrelapse mortality and overall survival. We defined IFD using standard criteria and selected proven and probable cases for analysis. Diagnoses in the study group included acute leukemia (42%), non-Hodgkin lymphoma (24%), myelodysplastic syndrome (15%), chronic lymphocytic leukemia (5%), and other hematologic disorders (14%). Conditioning included reduced-intensity (64%) and myeloablative (36%) regimens. Donor sou...
AbstractTo evaluate the clinical characteristics of invasive aspergillosis (IA) after reduced-intens...
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic...
AbstractInfections contribute significantly to morbidity and mortality after myeloablative allogenei...
BackgroundTo investigate the incidence and risk factors for the occurrence of proven or probable inv...
AbstractThe China Assessment of Antifungal Therapy in Hematological Disease study, the first large-s...
AbstractInvasive fungal infection (IFI) is a significant complication after allogeneic hematopoietic...
Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell...
AbstractIn recent years, we have successfully established a novel method of haploidentical haematopo...
Invasive fungal infections (IFIs) are a growing cause of morbidity and mortality in patients with ac...
Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell...
AbstractEpidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic s...
Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell...
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic...
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic...
AbstractThe aim of this study was to determine the incidence, clinical features and outcome of invas...
AbstractTo evaluate the clinical characteristics of invasive aspergillosis (IA) after reduced-intens...
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic...
AbstractInfections contribute significantly to morbidity and mortality after myeloablative allogenei...
BackgroundTo investigate the incidence and risk factors for the occurrence of proven or probable inv...
AbstractThe China Assessment of Antifungal Therapy in Hematological Disease study, the first large-s...
AbstractInvasive fungal infection (IFI) is a significant complication after allogeneic hematopoietic...
Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell...
AbstractIn recent years, we have successfully established a novel method of haploidentical haematopo...
Invasive fungal infections (IFIs) are a growing cause of morbidity and mortality in patients with ac...
Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell...
AbstractEpidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic s...
Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell...
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic...
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic...
AbstractThe aim of this study was to determine the incidence, clinical features and outcome of invas...
AbstractTo evaluate the clinical characteristics of invasive aspergillosis (IA) after reduced-intens...
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic...
AbstractInfections contribute significantly to morbidity and mortality after myeloablative allogenei...